Advocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices

Advocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices left Naresh Trehan, chairman and managing director of Medanta. File The Hindu The Hindu https://th-i.thgim.com/public/incoming/mwg7wp/article71621185.ece/alternates/FREE_1200/NDBL-3-1-11-22.jpg KAMAL NARANG B.LINE:Naresh Trehan, CMD global health Ltd at a press conference to announce about upcoming IPO.,in New Delhi on 1.11.22.Pic: Kamal Narang In a representation to the Department of Pharmaceuticals, the group urges the government to replace Medanta chairman with a member free of potential conflicts of interest. NEW DELHI The Working Group on Access to Medicines and Treatments has raised concerns over including Dr. Naresh Trehan, chairman and managing director of Medanta, in a committee constituted on the Supreme Court’s directions to examine the regulatory framework governing pharmaceutical marketing practices. https://www.thehindu.com/news/national/ed-files-money-laundering-case-against-naresh-trehan-others/article31796234.ece https://www.thehindu.com/news/national/sc-directs-centre-to-form-expert-panel-to-assess-statutory-backing-for-pharma-marketing-regulation/article71558619.ece In a representation to the Department of Pharmaceuticals, the advocacy group urged the government to replace Dr.